Sign Up Today and Learn More About SolasCure Stock
Invest in or calculate the value of your shares in SolasCure or other pre-IPO companies through EquityZen's platform.
SolasCure Stock (SOLC)
Solascure is a biotechnology company focused on the development of fit for purpose, efficacious wound care products.
About SolasCure Stock
Founded
2017
Industries
Software, Artificial Intelligence, Data and Analytics
SolasCure Press Mentions
Stay in the know about the latest news on SolasCure
SolasCure trial shows faster healing with Aurase Wound Gel
pharmatimes • Feb 28, 2026
SolasCure Completes Phase II Clinical Trial, Demonstrating Accelerated Healing With Aurase Wound Gel
businesswire • Feb 25, 2026
SolasCure Completes Phase II Clinical Trial, Demonstrating Accelerated Healing With Aurase Wound Gel
pharmiweb • Feb 25, 2026
FDA approval for SolasCure ulcer treatment widens market push
businessweekly • Jun 17, 2025
SolasCure receives FDA Fast Track Designation for Aurase Wound Gel to treat calciphylaxis ulcers
businesswire • Jun 16, 2025
SolasCure Management
Leadership team at SolasCure
Chief Development Officer
Aurelie Bouzelmat
Investor
Jonathan Milner
Join now and verify your accreditation status to gain access to:
- SolasCure Current Valuation
- SolasCure Stock Price
- SolasCure Management
- Available deals in SolasCure and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- SolasCure Cap Table and Funding History by Share Class and Liquidity Preferences
- SolasCure Revenue and Financials
- SolasCure Highlights
- SolasCure Business Model
- SolasCure Risk Factors
- SolasCure Research Report from SACRA Research
Trading SolasCure Stock
How to invest in SolasCure stock?
Accredited investors can buy pre-IPO stock in companies like SolasCure through EquityZen funds. These investments are made available by existing SolasCure shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell SolasCure stock?
Shareholders can sell their SolasCure stock through EquityZen's private company marketplace. EquityZen's network includes over 430K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
